As MMP-9 secretion promotes inflammation and destruction of lung tissue during lung injuries, it has been proposed that targeting MMP-9 activity could be beneficial in COVID-19, as well—especially because an increase in the MMP-9 level in circulating blood has been observed prior to respiratory failure in COVID-19 patients47. The gene discussed is MMP9; the disease is respiratory failure.